Role of interleukin 10 and transforming growth factor β1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 711-720

  Stearns, Mark E ^a   Garcia, Fernando U ^a   Fudge, Kim ^a   Rhim, Johng ^b   Wang, Min ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE A; INTERLEUKIN 10; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CANCER INHIBITION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; SCID MOUSE; TUMOR GROWTH;

ANIMALS; COLONY-FORMING UNITS ASSAY; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELATINASES; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MALE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033032231     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Huang, S., Xie, K., Bucana, C. D., Ullrich, S. E., and Bar-Eli, M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res., 2: 1969-1979, 1996.
2. Kundu, N., Beaty, T. L., Jackson, M. J., and Fulton, A. M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst., 88: 536-541, 1996.
3. Richiter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamantstain, T., and Blankenstein, T. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res., 53: 4134-4137, 1993.
4. Sato, T., McCue, P., Masuoka, K., Salwen, S., Lattime, E. D., Mastrangelo, M. J., and Berd, D. Interleukin 10 production by human melanoma. Clin. Cancer Res., 2: 1383-1390, 1996.
5. Nabioullin, R., Sone, S., Mizuno, K., Yano, S., Nishioka, Y., Haku, T., and Ogura, T. Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukocyte Biol., 55; 437-442, 1994.
6. Weiskirch, L. M., Bar-Dagan, Y., and Mokyr, M. B. Transforming growth factor-β mediated down regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor bearing mice engaged in tumor eradication following low dose melphalan therapy. Cancer Immunol. Immunother., 38: 215-236, 1994.
7. Gorelik, L., Prokhonova, A., and Mokyr, M. B. Low dose melphalan induced shift in the production of a Th-2 type cytokine to the Th1-type cytokine in mice bearing a large MOCP-315 tumor. Cancer Immunol. Immunother., 39: 117-123, 1994.
8. Maeda, H., Kuwahara, H., Ichimura, Y., Ohtsuki, M., Kurakata, S., and Shiraishi, A. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor bearing mice. J. Immunol., 81: 4926-4932, 1995.
9. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
10. Stearns, M., Wang, M., and Stearns, M. E. Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol. Res., 7: 173-181, 1995.
11. - subset. J. Exp. Med., 177: 1763-1771, 1993.
12. Tepper, R. I., and Mule, J. J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5: 153-164, 1994.
13. Marzo, A. L., Fitzpatrick, D. R., Robinson, B. W. S., and Scott, B. Antisense oligonucleotides specific for transforming growth factor β2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Cancer Res., 57: 3200-3207, 1997.
14. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
15. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchel, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.
16. Stearns, M. E., and Wang, M. Immunoassays of the metalloproteinase (MMP-2,9) and tissue inhibitor of metalloproteinase (TIMP-1,2) levels in non-invasive and metastatic PC-3 clones. Effects of Taxol. Oncol. Res., 6: 195-202, 1996.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Stearns, M. E., Fudge, K., Garcia, F., and Wang, M. Interleukin 10 inhibition of human prostate PC-3 ML cell metastases in SCID mice. IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Invasion Metastasis, 17: 62-74, 1997.
19. Denhardt, D. T., Feng, B., Dylan, R. E., Cocuzzi, E. T., and Malyankar, U. M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther., 59: 329-341, 1993.
20. Stetler-Stevenson, W. G. Type IV collagenase in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289-303, 1990.
21. Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
22. Ogilvie, S. J., Hailey, J. A., Juacaba, S. F., Lee, E. C. G., and Tarin, D. Collagenase secretion by human breast neoplasms: a clinicopathologic investigation. J. Natl. Cancer Inst., 74: 19-28, 1985.
23. r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res., 51: 439-444, 1991.
24. D'Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler-Stevenson, W. G., and Grigioni, W. F. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and beast carcinoma progression. Mod. Pathol., 4: 239-246, 1991.
25. Hewitt, R. E., Leach, I. H., Powe, D. G., Clark, I. M., Cawston, T. E., and Turner, D. R. Distribution of collagenase and tissue inhibitor of metalloproteinase (TIMP) in colorectal tumours. Int. J. Cancer, 49: 666-672, 1991.
26. Wood, M., Fudge, K., Mohler, J., Frost, A., Garcia, F., and Stearns, M. E. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis, 15: 246-258, 1997.
27. Roeb, E., Graeve, L., Hoffmann, R., Decker, K., Edwards, D. R., and Heinrich, P. C. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology, 18: 1437-1442, 1993.
28. Lacraz, S., Nicod, L., Rochemonteix, B. G., Baumberger, C., Dayer, J. M., and Welgus, H. G. J. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. Clin. Invest., 90: 382-388, 1993.
29. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., and Dayer, J-M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest., 96: 2304-2310, 1995.